HOOKIPA Pharma Inc. (HOOK)

Latest Insider Confidence Score

2025Q4

49.1
Bearish

Company insider confidence (by quarter)

2019Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Sofinnova Capital VI Fcpr 10% Owner 3,177,574 Apr 23, 2021
Sofinnova Partners SAS 10% Owner 3,177,574 Apr 23, 2021
Baker Bros. Advisors Lp Other 1,059,516 Apr 23, 2019
Baker Bros. Advisors (GP) LLC Other 1,059,516 Apr 23, 2019
Baker Felix Other 1,059,516 Apr 23, 2019

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 19, 2025 Oct 9, 2025 Peters Malte CEO Sell 26.3 -25,172 -31.66% ✗ $20.7K
Jul 22, 2025 Jul 23, 2025 Peters Malte CEO Sell 46.3 -29,176 -26.84% ✗ $26.8K
Jul 22, 2025 Jul 23, 2025 Coelho Mary Theresa CFO Sell 46.3 -13,609 -19.48% ✗ $12.5K
Jul 22, 2024 Jul 24, 2024 Coelho Mary Theresa CFO Neutral 90.0 +69,875 100.00% ✗ -
Jul 22, 2024 Jul 24, 2024 Peters Malte CEO Neutral 90.0 +108,695 100.00% ✗ -
Jul 22, 2024 Jul 24, 2024 Cassidy Sean A Director Neutral 52.5 - 0.00% ✗ -
Jul 24, 2024 Cassidy Sean A Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 Peters Malte Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 Kaufman David Ross Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 van de Winkel Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 O'Neill Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 Coelho Mary Theresa Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Jun 18, 2024 Reilly Timothy P. Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Orlinger Klaus Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Aldag Jorn CEO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Winderlich Mark Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Kandera Reinhard CFO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Necina Roman Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Apr 11, 2024 Winderlich Mark Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Aug 21, 2023 Aug 22, 2023 Kandera Reinhard CFO Buy 90.0 +7,000 19.39% ✗ $5.1K
Aug 16, 2023 Aug 17, 2023 Kandera Reinhard CFO Buy 90.0 +8,000 28.48% ✗ $5.7K
Jul 7, 2023 Jul 11, 2023 Aldag Jorn CEO Buy 90.0 +10,000 16.14% ✗ $8.2K
Jul 5, 2023 Jul 7, 2023 Aldag Jorn CEO Buy 85.0 +5,000 8.78% ✗ $4.5K
Jul 3, 2023 Jul 5, 2023 Aldag Jorn CEO Buy 85.0 +5,000 9.62% ✗ $4.5K
Jun 30, 2023 Jul 3, 2023 Kandera Reinhard CFO Buy 91.3 +12,000 74.57% ✗ $10.6K
Jun 9, 2023 Jun 9, 2023 Peters Malte Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 9, 2023 Reilly Timothy P. Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 9, 2023 O'Neill Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 9, 2023 van de Winkel Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 9, 2023 Kaufman David Ross Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 9, 2023 Coelho Mary Theresa Director Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Orlinger Klaus Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Necina Roman Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Schlienger Katia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Baker Christine D. COO Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Kandera Reinhard CFO Neutral 52.5 - 0.00% ✗ -
Apr 14, 2023 Apr 18, 2023 Aldag Jorn CEO Neutral 52.5 - 0.00% ✗ -
Apr 18, 2023 Schlienger Katia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 18, 2023 Peters Malte Director Neutral 52.5 - 0.00% ✗ -
Apr 4, 2023 Coelho Mary Theresa Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 van de Winkel Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Reilly Timothy P. Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Orlinger Klaus Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 O'Neill Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Necina Roman Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Matushansky Igor Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Kelly Michael Aaron Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Kaufman David Ross Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Kandera Reinhard CFO Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Baker Christine D. COO Neutral 52.5 - 0.00% ✗ -
Jun 30, 2022 Jul 1, 2022 Aldag Jorn CEO Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Orlinger Klaus Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Necina Roman Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Matushansky Igor Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Kandera Reinhard CFO Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Baker Christine D. Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2022 Apr 20, 2022 Aldag Jorn CEO Neutral 52.5 - 0.00% ✗ -
Apr 20, 2022 Reilly Timothy P. Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 1, 2022 Orlinger Klaus Executive VP, Research Neutral 90.0 +9,188 755.59% ✗ -
Feb 1, 2022 Feb 1, 2022 Baker Christine D. Chief Business Officer Neutral 90.0 +13,658 546.32% ✗ -
Feb 1, 2022 Feb 1, 2022 Necina Roman Chief Technology Officer Neutral 90.0 +12,892 649.80% ✗ -
Feb 1, 2022 Feb 1, 2022 Matushansky Igor Chief Medical Officer Neutral 90.0 +14,933 17.51% ✗ -
Feb 1, 2022 Feb 1, 2022 Kandera Reinhard CFO Neutral 90.0 +14,056 690.37% ✗ -
Feb 1, 2022 Feb 1, 2022 Aldag Jorn CEO Neutral 90.0 +47,824 1158.53% ✗ -
Dec 21, 2021 Jan 12, 2022 Matushansky Igor Chief Medical Officer Sell 26.3 -14,949 -5.65% ✗ $37.2K
Jun 14, 2021 Seghezzi Graziano Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 van de Winkel Jan Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 Soria Jean-Charles Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 Seghezzi Graziano Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 O'Neill Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 Lengauer Christoph Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 Kelly Michael Aaron Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2021 Jun 4, 2021 Kaufman David Ross Director Neutral 52.5 - 0.00% ✗ -
Apr 21, 2021 Apr 23, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 17.5 -328,620 -9.37% ✗ $3.8M
Apr 19, 2021 Apr 21, 2021 Necina Roman Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2021 Apr 21, 2021 Orlinger Klaus Sr. VP, Research Neutral 52.5 - 0.00% ✗ -
Apr 19, 2021 Apr 21, 2021 Baker Christine D. Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2021 Apr 21, 2021 Matushansky Igor Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 19, 2021 Apr 21, 2021 Kandera Reinhard CFO Neutral 52.5 - 0.00% ✗ -
Apr 19, 2021 Apr 21, 2021 Aldag Jorn CEO Neutral 52.5 - 0.00% ✗ -
Mar 29, 2021 Mar 31, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 42.5 -36,829 -1.04% ✓ $503.6K
Mar 26, 2021 Mar 31, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 45.0 -35,171 -0.98% ✓ $481.6K
Mar 25, 2021 Mar 29, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 45.0 -28,546 -0.79% ✓ $374.6K
Mar 24, 2021 Mar 26, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 42.5 -52,690 -1.44% ✓ $721.6K
Mar 23, 2021 Mar 25, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 42.5 -40,000 -1.08% ✓ $556.5K
Mar 22, 2021 Mar 24, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 42.5 -40,534 -1.08% ✓ $589.3K
Mar 19, 2021 Mar 23, 2021 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 32.5 -166,230 -4.26% ✓ $2.4M
Mar 22, 2021 Baker Christine D. Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2020 Dec 18, 2020 Matushansky Igor Chief Medical Officer Sell 20.0 -28,359 -12.53% ✗ $332.8K
Dec 15, 2020 Dec 17, 2020 Soria Jean-Charles Director Neutral 52.5 - 0.00% ✗ -
Oct 21, 2020 Oct 23, 2020 Seghezzi Graziano Director Neutral 90.0 +4,708 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 van Deventer Sander Director Neutral 90.0 +2,485 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 O'Neill Julie Director Neutral 90.0 +4,969 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 Lengauer Christoph Director Neutral 90.0 +4,603 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 Kaufman David Ross Director Neutral 90.0 +4,577 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 Kelly Michael Aaron Director Neutral 90.0 +5,754 100.00% ✗ -
Oct 21, 2020 Oct 23, 2020 van de Winkel Jan Director Neutral 90.0 +9,153 100.00% ✗ -
Oct 23, 2020 Soria Jean-Charles Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2020 Oct 6, 2020 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 58.8 -300 -0.01% ✓ $3K
Sep 15, 2020 Sep 17, 2020 SOFINNOVA CAPITAL VI FCPR 10% Owner Sell 42.5 -41,597 -1.05% ✓ $524.5K